Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-W019806 |
Brand: | MCE |
CAS: | 7578-25-8 |
MDL | - |
---|---|
Molecular Weight | 853.77 |
Molecular Formula | C32H55NO25 |
SMILES | CC(N[C@@H]1[C@H]([C@@H]([C@@H](CO)O[C@H]1O[C@]2([H])[C@H]([C@@H](O[C@H](CO)[C@@H]2O)O[C@@]([C@H](O)CO)([H])[C@H](O)[C@@H](O)C=O)O)O)O[C@@]3([H])[C@@H]([C@H]([C@@H](O)[C@@H](CO)O3)O)O[C@@]4([H])[C@H]([C@@H]([C@H](O)[C@H](C)O4)O)O)=O |
Lacto-N-fucopentaose I (LNFPI) is a human milk oligosaccharide (HMO), possessing antiviral and antibacterial activity. Lacto-N-fucopentaose I can reduce capsid protein VP1 to block virus adsorption, promote CDK2 and reduce cyclin E to recover cell cycle S phase block. Lacto-N-fucopentaose I inhibits ROS production and apoptosis in virus-infected cells. Lacto-N-fucopentaose I can also regulate intestinal microbiota to affect immune system development [1] .
Human Endogenous Metabolite
|
CDK2/cyclinE
|
Lacto-N-fucopentaose I (25-3200 μg/mL;48 h) exhibits certain cytotoxicity at 3200 μg/mL but no toxic reaction below 1600 μg/mL
[1]
.
Lacto-N-fucopentaose I (25-1600 μg/mL; 14-18 h) can protect EV71-infected RD cells from death
[1]
.
Lacto-N-fucopentaose I (100-400 μg/mL; 16 h) decreases markedly mRNA levels of VP1 and ROS production in EV71-infected RD cells at 400 μg/mL; leads to the recovery of EV71-induced S phase arrest in RD cells
[1]
.
Lacto-N-fucopentaose I (100 and 200 μg/mL; 3 days) inhibits cell apoptosis in
Caenorhabditis elegans
; significantly decreases the levels of
Egl-1
,
Ced-3
and
Ced-4
[1]
.
Lacto-N-fucopentaose I can reduce the abundance of
Sphingobacterium
,
Stenotrophomonas
and
Achromobacter
; can increase the abundance of
Micromonospora
,
Vibrio
,
Acidibacter
,
Gaiella
,
Devosia
,
Steroidobacter
,
Variibacter
,
Dactylosporangium
,
RB41
,
Pir4_lineage
,
Pirellula
,
Haliangium
,
Roseiflexus
,
Pedomicrobium
, and
Bradyrhizobium
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
Cell Line: | RD cells |
Concentration: | 25, 50, 100, 200, 400, 800, 1600 and 3200 μg/mL |
Incubation Time: | 48 h |
Result: | Exhibited certain cytotoxicity at 3200 μg/mL but no toxic reaction below 1600 μg/mL. |
RT-PCR [1]
Cell Line: | RD cells (infected with EV71) |
Concentration: | 100, 200 and 400 μg/mL |
Incubation Time: | 16 h |
Result: | Decreased markedly mRNA levels of VP1 only at 400 μg/mL. |
Apoptosis Analysis [1]
Cell Line: | RD cells (infected with EV71) |
Concentration: | 100, 200 and 400 μg/mL |
Incubation Time: | 16 h |
Result: |
Decreased the rate of cells in early apoptosis to 10.9% ± 1.26% at 400 μg/mL, while the untreated EV71 group was 27.7% ± 2.13%.
Significantly inhibited the activity of caspase-3, caspase-8 and caspase-9. Recovered the decreased mRNA expression of PAPR, NF-κB and Bcl-2 and properly regulated Bad and Fas into their normal levels. |
Cell Cycle Analysis [1]
Cell Line: | RD cells (infected with EV71) |
Concentration: | 100, 200 and 400 μg/mL |
Incubation Time: | 12 h |
Result: | Rescued EV71-induced S phase arrest, which promoted the transition of the G1 phase to the S phase. |
Solid
human milk
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.